8-K: iSpecimen Faces Nasdaq Delisting Warning Over Share Price

iSpecimen Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance.

Summary

• iSpecimen Inc. received a written notice from The Nasdaq Stock Market LLC on November 19, 2025, indicating non-compliance with the Minimum Bid Price Requirement.
• The company's common stock closing bid price has been below the minimum $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
• This notice does not immediately affect the listing of the company's common stock, which will continue to trade under the symbol ISPC.
• An initial 180-calendar-day period, until May 18, 2026, has been granted to regain compliance.
• Compliance can be regained if the closing bid price is at least $1.00 per share for a minimum of ten consecutive business days.
• If compliance is not regained by May 18, 2026, the company may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of its intent to cure, potentially through a reverse stock split.
• Failure to regain compliance within the applicable period will result in the common stock being subject to delisting, with the right to appeal to a Nasdaq hearings panel.

Sentiment

Score: 3

Explanation: The company received a delisting notice from Nasdaq due to its stock price falling below the minimum bid requirement, indicating significant share price underperformance and potential future challenges. While a compliance period exists, the underlying issue is negative.

Negatives

• The company's common stock has traded below the Nasdaq minimum bid price of $1.00 for 30 consecutive business days.
• Receipt of a formal delisting notice from Nasdaq indicates a significant challenge to maintaining listing status.
• The potential need for a reverse stock split could lead to share dilution or negative investor sentiment.

Risks

• Risk of delisting from The Nasdaq Capital Market if the company fails to regain compliance with the Minimum Bid Price Requirement.
• Inability to maintain a closing bid price of at least $1.00 for the required consecutive business days within the compliance period.
• Potential for a reverse stock split, which can sometimes be perceived negatively by investors and may not guarantee long-term compliance.
• Reduced liquidity and investor interest if the stock is delisted or faces prolonged uncertainty regarding its listing status.

Future Outlook

The company intends to monitor the closing bid price of its common stock and evaluate available options to regain compliance with the Minimum Bid Price Requirement, including potentially effectuating a reverse stock split if an additional compliance period is sought.

Management Comments

• "The Company intends to monitor the closing bid price of its common stock and evaluate available options to regain compliance with the Minimum Bid Price Requirement."

Industry Context

Receiving a delisting notice due to a low share price is a common challenge for smaller-cap companies, particularly those facing operational or market-related headwinds. Such notices can erode investor confidence, reduce trading liquidity, and make it more difficult to raise capital, potentially isolating the company from broader market trends and institutional investment.

Stakeholder Impact

• Shareholders face the risk of delisting, which could lead to reduced liquidity and potentially lower valuations.
• Shareholders may experience dilution if a reverse stock split is implemented without a proportional increase in market capitalization.
• Investor confidence may be negatively impacted by the uncertainty surrounding the company's Nasdaq listing status.

Next Steps

• Monitor the closing bid price of its common stock.
• Evaluate available options to regain compliance with the Minimum Bid Price Requirement.
• Potentially effectuate a reverse stock split if an additional compliance period is needed and other criteria are met.

Key Dates

Recommendation

The company's stock price has fallen below Nasdaq's minimum bid requirement, leading to a delisting notice. While there's a compliance period, the underlying share price weakness and the potential for a reverse stock split, which often dilutes existing shareholders and signals fundamental issues, present significant risks. A seasoned investor would likely consider selling or avoiding this stock due to the high uncertainty and negative catalyst.

Keywords

iSpecimen, ISPC, Nasdaq, delisting, minimum bid price, compliance, stock market, SEC filing, 8-K, reverse stock split